Skip to Main ContentSkip to Footer

Adrienne K. Conger MD

Assistant Professor of Medicine
Insurance Plans Accepted

Areas of Expertise

  • Pulmonary and Critical Care Medicine

Conditions and Treatments

Location

Vanderbilt Lung Institute One Hundred Oaks
Vanderbilt Lung Institute One Hundred Oaks
719 Thompson Lane, Suite 20300
Nashville, TN 37204

Services

Languages

  • English

Education

  • Doctor of Medicine - Tulane University, 2015
  • Internship - Vanderbilt University School of Medicine, 2016
  • Residency - Vanderbilt University School of Medicine, 2018
  • Fellowship - Vanderbilt University Medical Center, 2021

Board Certifications

  • Internal Medicine - American Board of Internal Medicine, 2018
  • Pulmonary Disease - American Board of Internal Medicine, 2020
  • Critical Care Medicine - American Board of Anesthesiology, 2021

Patient Comments

Patient Comments are gathered from the Press Ganey Patient Experience Survey and displayed in full. Patients are not identified in order to respect patient privacy.
Great listening skills at the apointment. Asked more questions as needed. Came up with a plan, made recomnedations.
September 14, 2026
Dr Krebs Conger was awesome. She listened attentively to me and asked numerous follow-up questions, to determine what was wrong with me. She is very personable, and friendly. She is an outstanding Doctor, in my opinion, and a credit to Vanderbilt.
September 8, 2026
Dr Conger easy to talk with and a great listener!
August 28, 2026
She is the very best doctor I've ever had at Vanderbilt. I just don't want her to get so busy with patients that she can't see me. I'm selfish!
July 22, 2026
Dr Conger is excellent and has helped me get medication I needed. She is so appreciated.
July 17, 2026
She was thorough and patient, made sure my questions were answered, and developed a proactive plan.
July 13, 2026
The best interaction and vey thorough.
June 12, 2026
Dr Conger is the best!!
April 29, 2026
Excellent visit with Dr. Conger. She is knowledgeable, compassionate and kind. Discussed risks, benefits and alternatives to evaluation and treatment options very well. Included me in decisions.
April 19, 2026